Fig. 2

Forest plot of the association between IgG seroprevalence and ACT treatment failure. ORs correspond to the odds of treatment failure after treatment with artemisinin containing mono- or combination therapy for seropositive versus seronegative individuals. *Estimates are calculated by the authors from data in the published paper, **estimates are published estimates. All estimates are unadjusted with the exception of Van Geertruyden et al. [28], which are adjusted for CD4+ count on day 0. Estimates for patients stratified by disease severity are reported where applicable. OR odds ratio, AM artemether, LM lumefantrine, SP sulfadoxine pyrimethamine, AS artesunate